Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
Research finds that older people’s sexual problems are being dismissed

Older people’s sexual activity problems and desires are being dismissed by health practitioners due to their age, a new study has suggested.

Published
08 December 2016
From
University of Manchester
The Unintended Consequences of AIDS Survival

A treatment activist chronicles the unique health and psychosocial challenges of long-term survivors and outlines goals for mobilization.

Published
07 December 2016
From
Poz
Why over 45s are at risk of sexually transmitted infections – new findings

Our research with heterosexual men and women in Glasgow aged between 45 and 65 explored not only what middle-aged adults know about HIV and other STIs but also the social circumstances surrounding that knowledge.

Published
05 December 2016
From
The Conversation
Ageing positively: the menopause in women living with HIV

Our team is conducting one of the largest studies to date in Europe, and the first ever in the UK, looking at how the menopause affects the health and wellbeing of women living with HIV.

Published
02 December 2016
From
National Institute for Health Research
Behavioral Therapy Provides Depression and Adherence Benefits in HIV Study

Four months of cognitive behavioral therapy for depression and antiretroviral adherence significantly improved adherence and depression scores when compared with treatment as usual in a three-way randomized trial involving adults with HIV infection. Relative improvements in adherence and depression held up in the eight months after the interventions ended.

Published
30 November 2016
From
The Body Pro
UNAIDS: Young African women are especially vulnerable to HIV/AIDS

The annual World AIDS Day report of the Joint United Nations Programme on HIV/AIDS (UNAIDS) offers a far more nuanced take on the epidemic than it has in previous years. For the first time, the report examines the disease in four age brackets that it calls “the life-cycle approach to HIV.” UNAIDS suggests this breakdown—0 to 14, 15 to 24, 25 to 49, and 50-plus—should lead to a clearer view of the epidemic’s “complex dynamics” and a more targeted response.

Published
23 November 2016
From
Science
Stopping a Silent Killer: Know the Facts About Heart Disease and HIV

Heart disease rates among people living with HIV are elevated compared to the general population. If you add to that the fact that heart disease is often a silent killer with atypical symptoms, it is easy to understand why more research needs to be conducted on this subject.

Published
21 November 2016
From
Positively Aware
Liver cancer risk reduced after hepatitis C treatment, but vigilance needed for aggressive cancers in months after treatment

People who are cured of hepatitis C after a course of direct-acting antiviral (DAA) treatment do not have a higher risk of developing liver cancer (hepatocellular carcinoma),

Published
14 November 2016
By
Keith Alcorn
Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV

A co-formulation of tenofovir alafenamide (TAF) plus emtricitabine, used with a third antiretroviral drug, maintained viral suppression as well as tenofovir disoproxil fumarate (TDF) plus emtricitabine in older

Published
10 November 2016
By
Liz Highleyman
Omega-3 fatty acids may reduce triglycerides and improve inflammation in people with HIV

Long-term use of omega-3 fatty acid supplements was associated with reduced levels of triglycerides and the inflammation biomarker C-reactive protein (CRP) in HIV-positive people with suppressed viral

Published
09 November 2016
By
Liz Highleyman
← First12345...148Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.